Cargando…

Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases

BACKGROUND: Recurrence of breast cancer after treatment is generally due to loco-regional invasion or distant metastasis. Although patients with metastasis are considered incurable, existing treatments might prolong a patient’s life while also improving its quality. Choice of approach for individual...

Descripción completa

Detalles Bibliográficos
Autores principales: Akbari, Mohammad Esmaeil, Rohani-Rasaf, Marzieh, Nafissi, Nahid, Akbari, Atieh, Shojaee, Leyla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031793/
https://www.ncbi.nlm.nih.gov/pubmed/29693352
http://dx.doi.org/10.22034/APJCP.2018.19.4.949
_version_ 1783337386026991616
author Akbari, Mohammad Esmaeil
Rohani-Rasaf, Marzieh
Nafissi, Nahid
Akbari, Atieh
Shojaee, Leyla
author_facet Akbari, Mohammad Esmaeil
Rohani-Rasaf, Marzieh
Nafissi, Nahid
Akbari, Atieh
Shojaee, Leyla
author_sort Akbari, Mohammad Esmaeil
collection PubMed
description BACKGROUND: Recurrence of breast cancer after treatment is generally due to loco-regional invasion or distant metastasis. Although patients with metastasis are considered incurable, existing treatments might prolong a patient’s life while also improving its quality. Choice of approach for individual patients requires identification of relevant survival factors. This study concerns factors influencing survival after recurrence in Iranian breast cancer patients. METHODS: This study was performed on 442 recurrent breast cancer patients referred to the Cancer Research Center of Shahid Beheshti University between 1985 and 2015. After confirming recurrence as a distant metastasis or loco-regional invasion, the effects of demographic, clinic-pathologic, biological, type of surgery and type of adjuvant treatment on survival were evaluated using univariate and multivariate stratified Cox models. RESULTS: The mean survival after recurrence was 18 months (5 days to 13 years), 219 patients (70.42%) survived two years, 75 patients (24.12%) survived from 2 to 5 years, and 17 patients (5.47%) survived more than 5 years. In this study, it was found through univariate analysis that the factors of age, lymph node status, DFI, place of recurrence and nodal ratio demonstrated greatest influence on survival after recurrence. On multivariate analysis, the most important factors influencing survival were the place of recurrence and the lymph node status. CONCLUSION: The results of this study enhance our knowledge of effects of different factors on survival of patients after breast cancer recurrence. Thus, they may be used to inform treatment choice.
format Online
Article
Text
id pubmed-6031793
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-60317932018-07-11 Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases Akbari, Mohammad Esmaeil Rohani-Rasaf, Marzieh Nafissi, Nahid Akbari, Atieh Shojaee, Leyla Asian Pac J Cancer Prev Research Article BACKGROUND: Recurrence of breast cancer after treatment is generally due to loco-regional invasion or distant metastasis. Although patients with metastasis are considered incurable, existing treatments might prolong a patient’s life while also improving its quality. Choice of approach for individual patients requires identification of relevant survival factors. This study concerns factors influencing survival after recurrence in Iranian breast cancer patients. METHODS: This study was performed on 442 recurrent breast cancer patients referred to the Cancer Research Center of Shahid Beheshti University between 1985 and 2015. After confirming recurrence as a distant metastasis or loco-regional invasion, the effects of demographic, clinic-pathologic, biological, type of surgery and type of adjuvant treatment on survival were evaluated using univariate and multivariate stratified Cox models. RESULTS: The mean survival after recurrence was 18 months (5 days to 13 years), 219 patients (70.42%) survived two years, 75 patients (24.12%) survived from 2 to 5 years, and 17 patients (5.47%) survived more than 5 years. In this study, it was found through univariate analysis that the factors of age, lymph node status, DFI, place of recurrence and nodal ratio demonstrated greatest influence on survival after recurrence. On multivariate analysis, the most important factors influencing survival were the place of recurrence and the lymph node status. CONCLUSION: The results of this study enhance our knowledge of effects of different factors on survival of patients after breast cancer recurrence. Thus, they may be used to inform treatment choice. West Asia Organization for Cancer Prevention 2018 /pmc/articles/PMC6031793/ /pubmed/29693352 http://dx.doi.org/10.22034/APJCP.2018.19.4.949 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Research Article
Akbari, Mohammad Esmaeil
Rohani-Rasaf, Marzieh
Nafissi, Nahid
Akbari, Atieh
Shojaee, Leyla
Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases
title Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases
title_full Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases
title_fullStr Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases
title_full_unstemmed Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases
title_short Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases
title_sort effecst of patho- biological factors on the survival of recurrent breast cancer cases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031793/
https://www.ncbi.nlm.nih.gov/pubmed/29693352
http://dx.doi.org/10.22034/APJCP.2018.19.4.949
work_keys_str_mv AT akbarimohammadesmaeil effecstofpathobiologicalfactorsonthesurvivalofrecurrentbreastcancercases
AT rohanirasafmarzieh effecstofpathobiologicalfactorsonthesurvivalofrecurrentbreastcancercases
AT nafissinahid effecstofpathobiologicalfactorsonthesurvivalofrecurrentbreastcancercases
AT akbariatieh effecstofpathobiologicalfactorsonthesurvivalofrecurrentbreastcancercases
AT shojaeeleyla effecstofpathobiologicalfactorsonthesurvivalofrecurrentbreastcancercases